Adaptiiv 3D Bolus Software Cleared

FDA has cleared an Adaptiiv 510(k) for its 3D Bolus Software for use in creating customized personal medical devices using 3D printing, primarily for use in treating cancer. The software allows practitioners 3D printing of patient-specific uniform thickness bolus, modulated bolus for MERT (modulated electron radiation therapy), High-Dose Rate surface brachytherapy and other potential ancillary devices.

“Adaptiiv software fully integrates with existing treatment planning systems and compliments the existing radiation treatment workflows,” the company says. “Each module of Adaptiiv's software is designed to solve challenges faced by today's therapists, dosimetrists, and oncologists such as air gaps in bolus, sparing healthy tissues in electron treatments and the fabrication of complex brachy devices.” The software is currently used in Canada, Australia, Israel, Ireland and England.